Engflag

Allergid

Quick links to important sections

Allergid

Allergid_HR

Method of action: Antiallergic, Antiexudative, Antihistamines For Systemic Use, Antipruritic

Treatment option: Atopic Dermatitis, Dermatitis, Blocked Nose, Jock Itch, Hives, Fever, Rhinitis, Hay Fever

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allergid

Quick Facts: Allergid (Cetirizine Hydrochloride)

Property Description
Active ingredient Cetirizine Hydrochloride
Form Oral preparations (Tablet, Solution)
Pharmacological class Second-generation H1-antihistamine
Common use Anti-allergic agent
Origin Synthetic, phenylmethyl-piperazine derivative

What Type of Medicine is Allergid? (Classification and Composition)

Allergid is a synthetic single-ingredient product whose therapeutic action is defined by its active ingredient, Cetirizine Hydrochloride. This substance is formally classified as a second-generation H1-antihistamine. The classification signifies that, unlike older compounds, Cetirizine is designed to primarily target peripheral receptors, a differentiating factor that minimizes the possibility of central nervous system effects. The preparation belongs to the piperazine class of antihistamines and is a phenylmethyl-piperazine derivative, reflecting its high-level chemical structure. It is typically supplied for oral systemic administration, commonly formulated as a tablet or oral solution, utilizing standard hydrophilic pharmaceutical excipients.

How Does the Antihistamine Cetirizine Work and What is its General Purpose?

The primary mechanism of action for Cetirizine Hydrochloride is selective histamine H1-receptor inhibition, functioning as a peripheral H1-blocker. This action involves binding to and blocking the histamine receptor sites, preventing the chemical histamine from initiating the allergic response cascade. Cetirizine possesses a rapid onset of action and high selectivity, supporting the general purpose of the long-acting preparation as an effective anti-allergic agent, used for typical situations requiring relief from allergic discomfort. Beyond simple histamine antagonism, the medication also possesses a secondary capacity to limit certain cellular processes involved in the late-phase allergic response, which contributes to its sustained therapeutic effect throughout the day.

Regulatory References

  1. NIH, MedlinePlus
  2. NIH, StatPearls

What side effects are possible with Allergid?

Possible Side Effects and Safety Information

The safety profile for Allergid, consistent with its drug class, is defined by both common, generally mild adverse reactions and a risk of rare, serious events. Official regulatory documentation classifies potential risks to ensure appropriate use and patient monitoring.

Common Adverse Reactions

Adverse effects reported frequently across the drug class typically involve the central nervous system and gastrointestinal systems. These reactions are often considered dose-dependent or predictable. Common reports include:

  • Drowsiness, fatigue, or mild sedation.
  • Dry mouth, headache.
  • Nausea or stomach upset.
  • Dizziness.

Serious and Clinically Significant Adverse Reactions

Although rare, serious adverse events require immediate attention and are mandatory safety subjects in regulatory documents. The most significant concern is the risk of anaphylaxis, a severe, life-threatening allergic reaction that can involve systemic symptoms such as difficulty breathing, swelling of the face or throat, and circulatory distress. Other serious documented risks include the potential for Severe Cutaneous Adverse Reactions (SCARs) and the worsening of pre-existing conditions.

Population-Specific Safety Considerations

Specific caution and monitoring are required for certain populations. Safety labels commonly address use in:

  • Pediatric Patients: Sensitivity to side effects may be increased.
  • Elderly Patients: Greater susceptibility to anticholinergic effects, such as confusion, dizziness, or urinary retention.
  • Patients with Pre-existing Conditions: Conditions like glaucoma, severe heart disease, or urinary retention typically require clinical review before use.

Safety Restrictions and Monitoring

The official framework emphasizes that taking higher than recommended doses can lead to serious adverse outcomes, including heart problems or seizures. Patients should avoid operating heavy machinery if drowsiness occurs. Regulatory oversight mandates that all known components and potential allergens must be meticulously documented to prevent inadvertent cross-contact.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the clinical presentation, required emergency actions, and management procedures for an Allergid (Cetirizine Hydrochloride) overdose.

Overdosage may present with somnolence, malaise, dizziness, or headache. In the pediatric population, presentation may involve paradoxical excitement, such as agitation or restlessness, which can precede CNS depression. Severe, high-risk outcomes documented in regulatory sources include convulsions, syncope, and coma.

Mandated Emergency Action

Domain Required Action (Official Statement)
Immediate Care Seek immediate medical help or contact a Poison Control Center right away upon any suspected overdose.
Life-Threatening Symptoms Call emergency services if severe manifestations occur, such as a seizure, trouble breathing, or inability to be awakened.

Management and Procedures

Official regulatory guidance states that no known specific antidote exists for Cetirizine. Treatment is therefore limited to symptomatic or supportive treatment. Gastric lavage may be considered shortly after ingestion, and hospital monitoring may be required for managing the overdose, particularly in cases involving large quantities or high-risk populations like geriatric patients, who exhibit reduced drug clearance.

Therapeutic Uses of Allergid

What Allergid Treats: Main Uses and Benefits

Allergid is relevant in clinical settings that involve acute or unstable symptom patterns driven by allergic responses. It is generally used to provide supportive symptomatic relief across key domains affected by heightened physiological activity. The medication is commonly applied for managing conditions characterized by episodic or fluctuating manifestations, including seasonal allergic rhinitis (hay fever), perennial allergic rhinitis (year-round allergies), and chronic idiopathic urticaria (hives).

Relief for Respiratory and Ocular Allergies

Allergid is commonly used to help with the characteristic oculonasal symptom clusters associated with both seasonal and perennial allergies. This includes prominent symptoms such as intense sneezing, rhinorrhea (runny nose), nasal itching, and symptoms related to physical discomfort in the eyes, such as tearing and redness. It provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during periods of heightened symptoms.

Management of Chronic Urticaria and Skin Pruritus

The medication is applied across domains where additional symptomatic support is needed for dermal manifestations of allergic reactions. It is relevant for addressing symptom clusters that may become intense or disruptive, such as persistent, widespread skin itching (pruritus) and the appearance of raised wheals and hives. This assists with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Therapeutic Scope of Symptom Relief

Symptom Category Relevance Patient Benefit Focus
Oculonasal Symptoms Conditions involving episodic or fluctuating manifestations Supports improved day-to-day comfort
Intense Skin Pruritus Applied across domains where additional symptomatic support is needed Helps ease the overall symptom burden
Allergic Wheals Relevant in conditions characterized by periods of heightened symptoms Assists with maintaining functional stability

Regulatory References

  1. NIH MedlinePlus overview of Cetirizine

Eligibility and Restrictions for Use

Who Can and Cannot Use Allergid?

Population eligibility for Allergid (Cetirizine Hydrochloride) is defined by regulatory authorities based on a patient's medical history, age, and organ function.

Contraindications

Use of Allergid is absolutely contraindicated (must not be used) in two primary groups:

  • Patients with a known hypersensitivity or allergy to Cetirizine, its excipients, its precursor Hydroxyzine, or any related piperazine derivatives.
  • Patients with severe renal impairment (typically defined as Creatinine Clearance less than 10 mL/min) or end-stage renal disease, due to the risk of drug accumulation.

Age and Conditional Use

Population Group Regulatory Eligibility Status
Adults and Adolescents (ge 12 years) Generally permitted for standard labeled use.
Children (2 to 6 years) Permitted, but only with specific oral solution/syrup formulations. The tablet is not recommended.
Pregnancy and Lactation Use is not recommended or should be avoided unless medically necessary, as the substance is excreted into breast milk.
Moderate Renal Impairment Conditional use; requires a reduced dosage to maintain safe levels.

Caution is also advised for patients with a risk of convulsions or a predisposition to urinary retention, as specified in official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Category Official Regulatory Information
Medicinal product categories with documented interactions Central Nervous System (CNS) Depressants, including sedatives, tranquilizers, and other sedating antihistamines.
Specific interacting medicines (if explicitly listed) Theophylline (400 mg dose), which causes a documented small decrease in Cetirizine clearance.
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic: Additive effects resulting in increased CNS depression. Pharmacokinetic: Cetirizine is classified as a P-glycoprotein (P-gp) substrate.
Timing-based interaction rules (if applicable) Food delays the rate of absorption (Tmax delayed) but does not alter the overall extent of absorption. No mandatory administration separation is specified.
Population-specific interaction notes (if applicable) Renal and/or Hepatic Impairment: Clearance may be reduced in patients with kidney or liver disease, potentially leading to higher systemic exposure.
Interaction-related restrictions Alcohol (Ethanol): Concurrent use should be avoided due to the potential for additive impairment of alertness and central nervous system performance.

Interaction Classifications (High-Level)

Classification Category Regulatory Basis
Interaction severity classification (as defined in official documents) Avoid Combination: For Alcohol. Use-with-Caution Combinations: For CNS Depressants.
Regulatory basis U.S. Food and Drug Administration (FDA) Prescribing Information and European Summary of Product Characteristics (SmPC) documents.
Interaction-context constraints (as defined in official documents) Official interaction studies found no clinically significant drug interactions with azithromycin, pseudoephedrine, ketoconazole, or erythromycin.

Resulting Interaction Structure

Official interaction statements:

  • Concurrent use with Alcohol and CNS Depressants is restricted due to the additive risk of reduced alertness.
  • Co-administration with Theophylline (400 mg daily) results in a small, documented decrease in the drug's clearance.
  • Clearance may be reduced in renal or hepatic impairment, increasing systemic exposure and potential for adverse pharmacodynamic effects.

Connection to the overall interaction profile (2–4 sentences):

Regulatory documents define the product's interaction structure based primarily on pharmacodynamic reinforcement with substances that cause central nervous system depression. This is complemented by a specific pharmacokinetic modification involving Theophylline and documented information on the drug being a P-glycoprotein substrate. Regulatory documents advise avoidance of alcohol due to the additive effects on performance.

Mechanism of Action

Allergid is a selective molecule that modulates the signaling cascade initiated by allergen exposure. Its mechanism of action involves the highly specific, competitive antagonism of the Histamine H₁ receptor ( H1). By binding to the H1 receptor, Allergid prevents histamine from initiating downstream cellular responses. This molecular interaction primarily impacts the excitability of sensory nerve endings and alters the vascular permeability response mediated by H1 activation. Furthermore, Allergid demonstrates activity that extends beyond immediate receptor blockade. The compound modulates intracellular NF-kappa B signaling, which is a key pathway regulating transcription of pro-inflammatory mediators. By influencing the NF-kappa B pathway, Allergid affects the delayed and sustained phases of the inflammatory response, impacting the expression of numerous cytokine genes. This dual effect results in a fundamental modulation of target cell responsiveness to inflammatory stimuli.

Dosage and Administration Information

Allergid (Cetirizine Hydrochloride) is administered via the Oral route (tablet or solution) for routine use, or via Intravenous (IV) injection for acute clinical needs. The medicine is designed for once-daily dosing, with the standard regimen for adults and adolescents 12 years and older being 10 mg once daily, although a starting dose of 5 mg may be utilized for less severe symptoms. The maximum oral dose should not exceed 10 mg in a 24-hour period.

Official Administration and Scheduling

Instruction Category Guideline
Dose Timing The oral dose may be administered with or without food, as the intake context does not affect absorption.
Duration of Use The medicine is used for both short-term relief of acute symptoms and long-term continuous use for chronic conditions.
Preparation Tablets must be swallowed whole with liquid. The oral solution requires the use of a proper measuring device for accurate dosing. Intravenous injection is administered as a slow push over 1 to 2 minutes.
Missed Dose If a regular dose is forgotten, it should be taken as soon as remembered that day, but double doses should not be taken to compensate.

Population-Specific Use Adjustments

Labeling requires dose modification based on patient characteristics, reflecting the drug's primary elimination route. Dose reduction is necessary for patients with renal impairment, where dosing frequency or dose strength must be adjusted according to the degree of reduced kidney function. Conversely, no dose adjustment is typically required for older adults who have normal renal function, nor is adjustment required for patients with solely hepatic impairment. The tablet form is not recommended for children under 6 years due to limitations in dose adaptation.

Recent Clinical Evidence

Allergid: Recent Clinical Evidence

This overview describes the types of research and clinical studies that have examined Allergid (Cetirizine Hydrochloride), focusing on what outcomes were measured and what the studies report concerning the patterns observed. This summary draws only from official regulatory and peer-reviewed scientific sources and does not offer clinical advice.

Evidence for Key Indications

For Seasonal Allergic Rhinitis (Hay Fever), studies were primarily conducted through short-term Randomized Controlled Trials (RCTs) and meta-analyses. The compound was studied for changes in symptoms over periods of increased allergen exposure. Data indicate patterns related to the compound's activity when observed alongside these acute changes compared to an inactive substance.

Research for Perennial Allergic Rhinitis (Year-Round Allergies) used multicenter trials and some longer observation periods. Studies explored the impact on patient-reported outcomes and daily functioning. Research reports that the compound was associated with differences in symptom scores when observed against an inactive substance.

In research concerning Chronic Idiopathic Urticaria (Hives), studies monitored outcomes related to inflammatory states in the skin, tracking measurements like the Urticaria Activity Score (UAS). Evidence contributes to understanding symptom patterns in conditions involving periods of heightened symptoms.

Research Limitations and Uncertainties

The results apply only to the populations studied, and follow-up durations were limited in most regulatory trials, typically spanning 2 to 8 weeks. Consequently, long-term effects are not fully established regarding the durability of the observed symptomatic change over many months. Evidence for use in the youngest pediatric populations (under two years) is limited, and comparative evidence is lacking for individuals with certain complex pre-existing conditions. Continued research is ongoing to address these knowledge gaps.

Key Studies & References

  1. Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Allergid (FAQ)

Q: What is Allergid and what is it used for?

A: Allergid is an antihistamine medication that contains the active ingredient fexofenadine. It is used to relieve the symptoms of seasonal allergic rhinitis, commonly known as hay fever, in adults and children 6 years of age and older. These symptoms include sneezing, runny nose, itchy or watery eyes, and an itchy nose or throat. It is also used to treat symptoms of chronic idiopathic urticaria (hives) in adults and children 6 years of age and older, such as itching and rash.

Q: How does Allergid work?

A: Allergid works by blocking the effects of histamine, a substance naturally produced by the body. Histamine is released during an allergic reaction and causes symptoms like sneezing, itching, and a runny nose. By blocking the histamine H1-receptor, Allergid prevents histamine from binding and causing these allergy symptoms.

Q: What is the recommended dosing for Allergid?

A: For adults and children 12 years and older with seasonal allergic rhinitis or chronic urticaria, the recommended dose of Allergid is typically 60 mg twice daily or 180 mg once daily. For children 6 to 11 years of age, the usual dose is 30 mg twice daily. Allergid should be taken with water, and generally, it is advised to avoid taking it with fruit juice, as this may reduce how much medication your body absorbs.

Q: What are the common side effects of Allergid?

A: Like all medications, Allergid may cause side effects, although not everyone gets them. Common side effects may include:

  • Headache
  • Drowsiness (though it is considered a non-drowsy antihistamine)
  • Dizziness
  • Nausea
  • Fatigue

If you experience any severe or persistent side effects, contact a healthcare professional.

Q: Can I take Allergid if I am pregnant or breastfeeding?

A: If you are pregnant, planning to become pregnant, or breastfeeding, it is important to talk to your healthcare provider before taking Allergid. Current information regarding its safety during pregnancy and breastfeeding is limited. A healthcare professional can weigh the potential benefits against any possible risks to the baby and advise you on the best course of action.

Q: Should I avoid any foods or drinks while taking Allergid?

A: It is generally recommended to avoid taking Allergid with fruit juices such as grapefruit, orange, or apple juice. These juices can interfere with the body's absorption of the medication, potentially reducing its effectiveness. It is best to take Allergid with water.

How should Allergid be stored and disposed of?

How to Store and Dispose of Allergid (Cetirizine Hydrochloride)

Storage and disposal must strictly adhere to official regulatory requirements to ensure product integrity and prevent accidental exposure.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 20 C and 25 C (68 F and 77 F).
Protection Keep away from excessive heat and high humidity.
Container Keep in the original container and ensure it is tightly closed.
Child Safety Store securely out of the sight and reach of children.

Disposal Instructions

Unused or expired medication should be disposed of through a drug take-back program. If this is unavailable, mix the medicine with an unappealing substance (like dirt or coffee grounds), place it in a sealed container, and discard it in the household trash. It is explicitly required not to flush this medicine down the toilet or pour it down any drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagPakistan

Equivalent of Allergid found in:

A-Z Index: